Chemoselective and Site‐Selective Lysine‐Directed Lysine Modification Enables Single‐Site Labeling of Native Proteins

The necessity for precision labeling of proteins emerged during the efforts to understand and regulate their structure and function. It demands selective attachment of tags such as affinity probes, fluorophores, and potent cytotoxins. Here, we report a method that enables single‐site labeling of a h...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Angewandte Chemie International Edition 2020-06, Vol.59 (26), p.10332-10336
Hauptverfasser: Adusumalli, Srinivasa Rao, Rawale, Dattatraya Gautam, Thakur, Kalyani, Purushottam, Landa, Reddy, Neelesh C., Kalra, Neetu, Shukla, Sanjeev, Rai, Vishal
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 10336
container_issue 26
container_start_page 10332
container_title Angewandte Chemie International Edition
container_volume 59
creator Adusumalli, Srinivasa Rao
Rawale, Dattatraya Gautam
Thakur, Kalyani
Purushottam, Landa
Reddy, Neelesh C.
Kalra, Neetu
Shukla, Sanjeev
Rai, Vishal
description The necessity for precision labeling of proteins emerged during the efforts to understand and regulate their structure and function. It demands selective attachment of tags such as affinity probes, fluorophores, and potent cytotoxins. Here, we report a method that enables single‐site labeling of a high‐frequency Lys residue in the native proteins. At first, the enabling reagent forms stabilized imines with multiple solvent‐accessible Lys residues chemoselectively. These linchpins create the opportunity to regulate the position of a second Lys‐selective electrophile connected by a spacer. Consequently, it enables the irreversible single‐site labeling of a Lys residue independent of its place in the reactivity order. The user‐friendly protocol involves a series of steps to deconvolute and address chemoselectivity, site‐selectivity, and modularity. Also, it delivers ordered immobilization and analytically pure probe‐tagged proteins. Besides, the methodology provides access to antibody‐drug conjugate (ADC), which exhibits highly selective anti‐proliferative activity towards HER‐2 expressing SKBR‐3 breast cancer cells. A chemical methodology finally addresses the undefeated challenge of modular and precision engineering of a Lys residue in a native protein. The remarkable control over selectivity provides the first‐ever approach to target Lys beyond the protein‐defined reactivity hotspot. This technology unfolds new gateways and renders analytically pure protein bioconjugates and homogeneous antibody‐drug conjugates.
doi_str_mv 10.1002/anie.202000062
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2377344350</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2412793940</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4102-15dff5735d01822bbd862af130c1377612b975ddb2434137b5d2b94e1b45f96c3</originalsourceid><addsrcrecordid>eNqFkb1OIzEYRS3ECligpUQj0dBM8O_8lChkdyOFgBSoLXv8DRhNbBhPWEU0PALPyJOsh2SDRIMbW1fnO7J9EToieEAwpmfKWRhQTHFcGd1Ce0RQkrI8Z9vxzBlL80KQXfQzhIfIFwXOdtAuoyQnmIs99DK8h7kP0EDV2WdIlDPJzHbw_vo224STZbCujy5sGyMw6yS59MbWtlKd9S4ZOaUbCHHc3TUfguhJJkpDE5PE18lUfeiuW9-BdeEA_ahVE-Bwve-j21-jm-GfdHL1ezw8n6QVJ5imRJi6FjkTBpOCUq1NkVFVE4YrEh-aEarLXBijKWc8JlqYmHAgmou6zCq2j05X3sfWPy0gdHJuQwVNoxz4RZC0_y7OmcARPfmCPvhF6-LtJOWE5iUreU8NVlTV-hBaqOVja-eqXUqCZV-L7GuRm1riwPFau9BzMBv8fw8RKFfAX9vA8hudPJ-OR5_yfy1Sm-Q</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2412793940</pqid></control><display><type>article</type><title>Chemoselective and Site‐Selective Lysine‐Directed Lysine Modification Enables Single‐Site Labeling of Native Proteins</title><source>MEDLINE</source><source>Access via Wiley Online Library</source><creator>Adusumalli, Srinivasa Rao ; Rawale, Dattatraya Gautam ; Thakur, Kalyani ; Purushottam, Landa ; Reddy, Neelesh C. ; Kalra, Neetu ; Shukla, Sanjeev ; Rai, Vishal</creator><creatorcontrib>Adusumalli, Srinivasa Rao ; Rawale, Dattatraya Gautam ; Thakur, Kalyani ; Purushottam, Landa ; Reddy, Neelesh C. ; Kalra, Neetu ; Shukla, Sanjeev ; Rai, Vishal</creatorcontrib><description>The necessity for precision labeling of proteins emerged during the efforts to understand and regulate their structure and function. It demands selective attachment of tags such as affinity probes, fluorophores, and potent cytotoxins. Here, we report a method that enables single‐site labeling of a high‐frequency Lys residue in the native proteins. At first, the enabling reagent forms stabilized imines with multiple solvent‐accessible Lys residues chemoselectively. These linchpins create the opportunity to regulate the position of a second Lys‐selective electrophile connected by a spacer. Consequently, it enables the irreversible single‐site labeling of a Lys residue independent of its place in the reactivity order. The user‐friendly protocol involves a series of steps to deconvolute and address chemoselectivity, site‐selectivity, and modularity. Also, it delivers ordered immobilization and analytically pure probe‐tagged proteins. Besides, the methodology provides access to antibody‐drug conjugate (ADC), which exhibits highly selective anti‐proliferative activity towards HER‐2 expressing SKBR‐3 breast cancer cells. A chemical methodology finally addresses the undefeated challenge of modular and precision engineering of a Lys residue in a native protein. The remarkable control over selectivity provides the first‐ever approach to target Lys beyond the protein‐defined reactivity hotspot. This technology unfolds new gateways and renders analytically pure protein bioconjugates and homogeneous antibody‐drug conjugates.</description><edition>International ed. in English</edition><identifier>ISSN: 1433-7851</identifier><identifier>EISSN: 1521-3773</identifier><identifier>DOI: 10.1002/anie.202000062</identifier><identifier>PMID: 32171045</identifier><language>eng</language><publisher>Germany: Wiley Subscription Services, Inc</publisher><subject>Antibodies ; antibody-drug conjugate ; Antineoplastic Agents - chemistry ; Antineoplastic Agents - pharmacology ; bioconjugation ; Breast cancer ; Cell Line, Tumor ; Chemical compounds ; Cytotoxins ; Drug Screening Assays, Antitumor ; Fluorescence ; Fluorescent Dyes - chemistry ; Fluorophores ; Humans ; Imines ; Immobilization ; Indicators and Reagents - chemistry ; Labeling ; Lysine ; Lysine - analogs &amp; derivatives ; lysine labeling ; Maytansine - chemistry ; Maytansine - pharmacology ; Modularity ; protein modification ; Proteins ; Proteins - chemistry ; Reagents ; Residues ; Selectivity ; Structure-function relationships ; Trastuzumab - chemistry</subject><ispartof>Angewandte Chemie International Edition, 2020-06, Vol.59 (26), p.10332-10336</ispartof><rights>2020 Wiley‐VCH Verlag GmbH &amp; Co. KGaA, Weinheim</rights><rights>2020 Wiley-VCH Verlag GmbH &amp; Co. KGaA, Weinheim.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4102-15dff5735d01822bbd862af130c1377612b975ddb2434137b5d2b94e1b45f96c3</citedby><cites>FETCH-LOGICAL-c4102-15dff5735d01822bbd862af130c1377612b975ddb2434137b5d2b94e1b45f96c3</cites><orcidid>0000-0003-3361-0588 ; 0000-0001-6263-7072 ; 0000-0002-6078-3516 ; 0000-0002-1448-5737 ; 0000-0001-6859-6451 ; 0000-0001-8856-3278 ; 0000-0002-8335-0641 ; 0000-0001-7504-8787</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fanie.202000062$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fanie.202000062$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1417,27924,27925,45574,45575</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32171045$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Adusumalli, Srinivasa Rao</creatorcontrib><creatorcontrib>Rawale, Dattatraya Gautam</creatorcontrib><creatorcontrib>Thakur, Kalyani</creatorcontrib><creatorcontrib>Purushottam, Landa</creatorcontrib><creatorcontrib>Reddy, Neelesh C.</creatorcontrib><creatorcontrib>Kalra, Neetu</creatorcontrib><creatorcontrib>Shukla, Sanjeev</creatorcontrib><creatorcontrib>Rai, Vishal</creatorcontrib><title>Chemoselective and Site‐Selective Lysine‐Directed Lysine Modification Enables Single‐Site Labeling of Native Proteins</title><title>Angewandte Chemie International Edition</title><addtitle>Angew Chem Int Ed Engl</addtitle><description>The necessity for precision labeling of proteins emerged during the efforts to understand and regulate their structure and function. It demands selective attachment of tags such as affinity probes, fluorophores, and potent cytotoxins. Here, we report a method that enables single‐site labeling of a high‐frequency Lys residue in the native proteins. At first, the enabling reagent forms stabilized imines with multiple solvent‐accessible Lys residues chemoselectively. These linchpins create the opportunity to regulate the position of a second Lys‐selective electrophile connected by a spacer. Consequently, it enables the irreversible single‐site labeling of a Lys residue independent of its place in the reactivity order. The user‐friendly protocol involves a series of steps to deconvolute and address chemoselectivity, site‐selectivity, and modularity. Also, it delivers ordered immobilization and analytically pure probe‐tagged proteins. Besides, the methodology provides access to antibody‐drug conjugate (ADC), which exhibits highly selective anti‐proliferative activity towards HER‐2 expressing SKBR‐3 breast cancer cells. A chemical methodology finally addresses the undefeated challenge of modular and precision engineering of a Lys residue in a native protein. The remarkable control over selectivity provides the first‐ever approach to target Lys beyond the protein‐defined reactivity hotspot. This technology unfolds new gateways and renders analytically pure protein bioconjugates and homogeneous antibody‐drug conjugates.</description><subject>Antibodies</subject><subject>antibody-drug conjugate</subject><subject>Antineoplastic Agents - chemistry</subject><subject>Antineoplastic Agents - pharmacology</subject><subject>bioconjugation</subject><subject>Breast cancer</subject><subject>Cell Line, Tumor</subject><subject>Chemical compounds</subject><subject>Cytotoxins</subject><subject>Drug Screening Assays, Antitumor</subject><subject>Fluorescence</subject><subject>Fluorescent Dyes - chemistry</subject><subject>Fluorophores</subject><subject>Humans</subject><subject>Imines</subject><subject>Immobilization</subject><subject>Indicators and Reagents - chemistry</subject><subject>Labeling</subject><subject>Lysine</subject><subject>Lysine - analogs &amp; derivatives</subject><subject>lysine labeling</subject><subject>Maytansine - chemistry</subject><subject>Maytansine - pharmacology</subject><subject>Modularity</subject><subject>protein modification</subject><subject>Proteins</subject><subject>Proteins - chemistry</subject><subject>Reagents</subject><subject>Residues</subject><subject>Selectivity</subject><subject>Structure-function relationships</subject><subject>Trastuzumab - chemistry</subject><issn>1433-7851</issn><issn>1521-3773</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkb1OIzEYRS3ECligpUQj0dBM8O_8lChkdyOFgBSoLXv8DRhNbBhPWEU0PALPyJOsh2SDRIMbW1fnO7J9EToieEAwpmfKWRhQTHFcGd1Ce0RQkrI8Z9vxzBlL80KQXfQzhIfIFwXOdtAuoyQnmIs99DK8h7kP0EDV2WdIlDPJzHbw_vo224STZbCujy5sGyMw6yS59MbWtlKd9S4ZOaUbCHHc3TUfguhJJkpDE5PE18lUfeiuW9-BdeEA_ahVE-Bwve-j21-jm-GfdHL1ezw8n6QVJ5imRJi6FjkTBpOCUq1NkVFVE4YrEh-aEarLXBijKWc8JlqYmHAgmou6zCq2j05X3sfWPy0gdHJuQwVNoxz4RZC0_y7OmcARPfmCPvhF6-LtJOWE5iUreU8NVlTV-hBaqOVja-eqXUqCZV-L7GuRm1riwPFau9BzMBv8fw8RKFfAX9vA8hudPJ-OR5_yfy1Sm-Q</recordid><startdate>20200622</startdate><enddate>20200622</enddate><creator>Adusumalli, Srinivasa Rao</creator><creator>Rawale, Dattatraya Gautam</creator><creator>Thakur, Kalyani</creator><creator>Purushottam, Landa</creator><creator>Reddy, Neelesh C.</creator><creator>Kalra, Neetu</creator><creator>Shukla, Sanjeev</creator><creator>Rai, Vishal</creator><general>Wiley Subscription Services, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TM</scope><scope>K9.</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-3361-0588</orcidid><orcidid>https://orcid.org/0000-0001-6263-7072</orcidid><orcidid>https://orcid.org/0000-0002-6078-3516</orcidid><orcidid>https://orcid.org/0000-0002-1448-5737</orcidid><orcidid>https://orcid.org/0000-0001-6859-6451</orcidid><orcidid>https://orcid.org/0000-0001-8856-3278</orcidid><orcidid>https://orcid.org/0000-0002-8335-0641</orcidid><orcidid>https://orcid.org/0000-0001-7504-8787</orcidid></search><sort><creationdate>20200622</creationdate><title>Chemoselective and Site‐Selective Lysine‐Directed Lysine Modification Enables Single‐Site Labeling of Native Proteins</title><author>Adusumalli, Srinivasa Rao ; Rawale, Dattatraya Gautam ; Thakur, Kalyani ; Purushottam, Landa ; Reddy, Neelesh C. ; Kalra, Neetu ; Shukla, Sanjeev ; Rai, Vishal</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4102-15dff5735d01822bbd862af130c1377612b975ddb2434137b5d2b94e1b45f96c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Antibodies</topic><topic>antibody-drug conjugate</topic><topic>Antineoplastic Agents - chemistry</topic><topic>Antineoplastic Agents - pharmacology</topic><topic>bioconjugation</topic><topic>Breast cancer</topic><topic>Cell Line, Tumor</topic><topic>Chemical compounds</topic><topic>Cytotoxins</topic><topic>Drug Screening Assays, Antitumor</topic><topic>Fluorescence</topic><topic>Fluorescent Dyes - chemistry</topic><topic>Fluorophores</topic><topic>Humans</topic><topic>Imines</topic><topic>Immobilization</topic><topic>Indicators and Reagents - chemistry</topic><topic>Labeling</topic><topic>Lysine</topic><topic>Lysine - analogs &amp; derivatives</topic><topic>lysine labeling</topic><topic>Maytansine - chemistry</topic><topic>Maytansine - pharmacology</topic><topic>Modularity</topic><topic>protein modification</topic><topic>Proteins</topic><topic>Proteins - chemistry</topic><topic>Reagents</topic><topic>Residues</topic><topic>Selectivity</topic><topic>Structure-function relationships</topic><topic>Trastuzumab - chemistry</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Adusumalli, Srinivasa Rao</creatorcontrib><creatorcontrib>Rawale, Dattatraya Gautam</creatorcontrib><creatorcontrib>Thakur, Kalyani</creatorcontrib><creatorcontrib>Purushottam, Landa</creatorcontrib><creatorcontrib>Reddy, Neelesh C.</creatorcontrib><creatorcontrib>Kalra, Neetu</creatorcontrib><creatorcontrib>Shukla, Sanjeev</creatorcontrib><creatorcontrib>Rai, Vishal</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Nucleic Acids Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><jtitle>Angewandte Chemie International Edition</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Adusumalli, Srinivasa Rao</au><au>Rawale, Dattatraya Gautam</au><au>Thakur, Kalyani</au><au>Purushottam, Landa</au><au>Reddy, Neelesh C.</au><au>Kalra, Neetu</au><au>Shukla, Sanjeev</au><au>Rai, Vishal</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Chemoselective and Site‐Selective Lysine‐Directed Lysine Modification Enables Single‐Site Labeling of Native Proteins</atitle><jtitle>Angewandte Chemie International Edition</jtitle><addtitle>Angew Chem Int Ed Engl</addtitle><date>2020-06-22</date><risdate>2020</risdate><volume>59</volume><issue>26</issue><spage>10332</spage><epage>10336</epage><pages>10332-10336</pages><issn>1433-7851</issn><eissn>1521-3773</eissn><abstract>The necessity for precision labeling of proteins emerged during the efforts to understand and regulate their structure and function. It demands selective attachment of tags such as affinity probes, fluorophores, and potent cytotoxins. Here, we report a method that enables single‐site labeling of a high‐frequency Lys residue in the native proteins. At first, the enabling reagent forms stabilized imines with multiple solvent‐accessible Lys residues chemoselectively. These linchpins create the opportunity to regulate the position of a second Lys‐selective electrophile connected by a spacer. Consequently, it enables the irreversible single‐site labeling of a Lys residue independent of its place in the reactivity order. The user‐friendly protocol involves a series of steps to deconvolute and address chemoselectivity, site‐selectivity, and modularity. Also, it delivers ordered immobilization and analytically pure probe‐tagged proteins. Besides, the methodology provides access to antibody‐drug conjugate (ADC), which exhibits highly selective anti‐proliferative activity towards HER‐2 expressing SKBR‐3 breast cancer cells. A chemical methodology finally addresses the undefeated challenge of modular and precision engineering of a Lys residue in a native protein. The remarkable control over selectivity provides the first‐ever approach to target Lys beyond the protein‐defined reactivity hotspot. This technology unfolds new gateways and renders analytically pure protein bioconjugates and homogeneous antibody‐drug conjugates.</abstract><cop>Germany</cop><pub>Wiley Subscription Services, Inc</pub><pmid>32171045</pmid><doi>10.1002/anie.202000062</doi><tpages>5</tpages><edition>International ed. in English</edition><orcidid>https://orcid.org/0000-0003-3361-0588</orcidid><orcidid>https://orcid.org/0000-0001-6263-7072</orcidid><orcidid>https://orcid.org/0000-0002-6078-3516</orcidid><orcidid>https://orcid.org/0000-0002-1448-5737</orcidid><orcidid>https://orcid.org/0000-0001-6859-6451</orcidid><orcidid>https://orcid.org/0000-0001-8856-3278</orcidid><orcidid>https://orcid.org/0000-0002-8335-0641</orcidid><orcidid>https://orcid.org/0000-0001-7504-8787</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 1433-7851
ispartof Angewandte Chemie International Edition, 2020-06, Vol.59 (26), p.10332-10336
issn 1433-7851
1521-3773
language eng
recordid cdi_proquest_miscellaneous_2377344350
source MEDLINE; Access via Wiley Online Library
subjects Antibodies
antibody-drug conjugate
Antineoplastic Agents - chemistry
Antineoplastic Agents - pharmacology
bioconjugation
Breast cancer
Cell Line, Tumor
Chemical compounds
Cytotoxins
Drug Screening Assays, Antitumor
Fluorescence
Fluorescent Dyes - chemistry
Fluorophores
Humans
Imines
Immobilization
Indicators and Reagents - chemistry
Labeling
Lysine
Lysine - analogs & derivatives
lysine labeling
Maytansine - chemistry
Maytansine - pharmacology
Modularity
protein modification
Proteins
Proteins - chemistry
Reagents
Residues
Selectivity
Structure-function relationships
Trastuzumab - chemistry
title Chemoselective and Site‐Selective Lysine‐Directed Lysine Modification Enables Single‐Site Labeling of Native Proteins
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-03T08%3A14%3A36IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Chemoselective%20and%20Site%E2%80%90Selective%20Lysine%E2%80%90Directed%20Lysine%20Modification%20Enables%20Single%E2%80%90Site%20Labeling%20of%20Native%20Proteins&rft.jtitle=Angewandte%20Chemie%20International%20Edition&rft.au=Adusumalli,%20Srinivasa%20Rao&rft.date=2020-06-22&rft.volume=59&rft.issue=26&rft.spage=10332&rft.epage=10336&rft.pages=10332-10336&rft.issn=1433-7851&rft.eissn=1521-3773&rft_id=info:doi/10.1002/anie.202000062&rft_dat=%3Cproquest_cross%3E2412793940%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2412793940&rft_id=info:pmid/32171045&rfr_iscdi=true